Sfoglia per Autore
The Combination of Everolimus and Low Dose Cyclosporine Allows Similar Results as the Standard Tacrolimus and MMF Regimen: 3-Year Results of a Prospective Clinical Trial in Renal Transplant Recipients
2010 E. Favi, G. Spagnoletti, A. Gargiulo, J. Romagnoli, M. Castagneto, F. Citterio
Lower Acute Rejection with Basiliximab and Short Course, Low Dose Thymoglobulin vs Basiliximab as Induction Therapy in Deceased Donor Renal Transplant Recipients: 6-Month Results of a Prospective Clinical Trial
2010 E. Favi, N. Silvestrini, I. Valente, M. Salerno, M. Castagneto, F. Citterio
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study
2010 E. Favi, G. Spagnoletti, A. Gargiulo, M.P. Salerno, J. Romagnoli, F. Citterio
Significant improvement in patient survival after renal transplantation in the last decade
2011 E. Favi, M.P. Salerno, J. Romagnoli, M. Castagneto, F. Citterio
Metabolic syndrome and cardiovascular disease in kidney transplantation
2011 M.P. Salerno, P. Piselli, E. Rossi, E. Favi, A. Gargiulo, G. Spagnoletti, A. Agresta, F. Citterio
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study
2011 E. Favi, N. Silvestrini, G. Spagnoletti, J. Romagnoli, M. Castagneto, F. Citterio
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-Year results of a pilot study
2011 G. Spagnoletti, E. Favi, A. Gargiulo, M.P. Salerno, F. Citterio
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial
2011 E. Favi, N. Silvestrini, G. Spagnoletti, M. Castagneto, F. Citterio
Induction with Thymoglobulin Plus Basiliximab Is Safe and Effective in Expanded Criteria Donor Kidney Transplant Recipients: 1-Year Results of a Prospective Clinical Trial
2012 E. Favi, N. Silvestrini, J. Romagnoli, M.P. Salerno, J.A. Pedroso, F. Citterio
Extended-release tacrolimus plus everolimus or micophenolate mofetil in deceased donor kidney transplant recipients : 6-month results of a prospective randomized clinical trial
2012 E. Favi, N. Silvestrini, M.P. Salerno, J. Romagnoli, F. Citterio
Extended-Release Tacrolimus Plus Everolimus vs Extended-Release Tacrolimus Plus Micophenolate Mofetil in Primary Deceased Donor Kidney Transplant Recipients: 1-Year Results of an Open Label, Randomized Phase 2 Clinical Trial
2013 E. Favi, N. Silvestrini, J. Pedroso, M. Salerno, G. Spagnoletti, V. Bianchi, J. Romagnoli, F. Citterio
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen
2013 M.P. Salerno, E. Rossi, E. Favi, J.A. Pedroso, G. Spagnoletti, J. Romagnoli, F. Citterio
Mini-invasive living donor nephrectomy using the hand-assited laparoscopic technique: our first experience
2013 J. Romagnoli, M.P. Salerno, N. Mamode, F. Calder, J.A. Pedroso, E. Favi, G. Spagnoletti, V. Bianchi, F. Citterio
ER-tacrolimus plus everolimus vs ER-tacrolimus plus MMF in primary deceased donor kidney transplantation: 1-year results of single center, open label, prospective, randomized clinical trial
2013 E. Favi, N. Silvestrini, J.A. Pedroso, M.P. Salerno, G. Spagnoletti, J. Romagnoli, F. Citterio
Thymoglobulin plus basilixab versus basiliximab induction in deceased donor kidney transplant recipients treated with tacrolimus and: 1-year results of a prospective clinical trial
2013 E. Favi, G. Spagnoletti, N. Silvestrini, M.P. Salerno, J.A. Pedroso, J. Romagnoli, F. Citterio
Thymoglobulin Plus Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: 1-Year Results of a Prospective Clinical Trial
2013 E. Favi, G. Spagnoletti, N. Silvestrini, M.P. Salerno, J.A. Pedroso, J. Romagnoli, F. Citterio
Mini-invase living donor nephrectomy using the hand-assisted laparoscopic technique: our first experience
2013 J. Romagnoli, M.P. Salerno, N. Mamode, F. Calder, J.A. Pedroso, E. Favi, G. Spagnoletti, V. Bianchi, F. Citterio
Hand-assisted laparoscopic nephrectomy for renal cell carcinoma in renal transplant recipients and patients with end-stage renal disease
2013 J. Romagnoli, M.P. Salerno, R. Iezzi, J.A. Pedroso, G. Spagnoletti, E. Favi, V. Bianchi, F. Citterio
Conversion from prograf to extended-release tacrolimus in stable kidney transplant recipients: better renal function after 3 year follow up
2013 G. Spagnoletti, A. Gargiulo, E. Favi, M.P. Salerno, J.A. Pedroso, R. Calia, J. Romagnoli, F. Citterio
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients : Three-yr results of a single-center prospective clinical trial
2013 E. Favi, G. Spagnoletti, M.P. Salerno, J.A. Pedroso, J. Romagnoli, F. Citterio
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile